These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15373173)

  • 21. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Korea: a prospective, noncontrolled, observational cohort study.
    Lee SH; Chung BH; Kim CS; Lee HM; Kim CI; Yoo TK; Lee KS; Park KS; Byun SS; Yoon BI; Kim SW; Lee JY
    Urology; 2012 Jun; 79(6):1379-84. PubMed ID: 22503769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Present practice and development of minimally invasive techniques, imaging and training in European urology: results of a survey of the European Society of Uro-Technology (ESUT).
    de la Rosette JJ; Gravas S; Muschter R; Rassweiler J; Joyce A;
    Eur Urol; 2003 Sep; 44(3):346-51. PubMed ID: 12932934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence.
    Welliver C; MacLachlan LS; Riggs S; Kukreja JB; Miles-Thomas J
    Urol Pract; 2024 Nov; 11(6):950-955. PubMed ID: 39196671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.
    Doolin J; Reese ZA; Mukamal KJ
    World J Urol; 2021 Mar; 39(3):855-860. PubMed ID: 32448971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council.
    Ramsey EW; Elhilali M; Goldenberg SL; Nickel CJ; Norman R; Perreault JP; Piercy B; Trachtenberg J
    J Urol; 2000 Feb; 163(2):499-502. PubMed ID: 10647665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How to evaluate BPH-related SBAUs in clinical practice and research?].
    Descazeaud A; Robert G; de La Taille A
    Prog Urol; 2018 Nov; 28(15):830-838. PubMed ID: 30220536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.
    Lee SH; Kim DK; Kim JC; Lee KS; Lee JG; Park CH; Hong SJ; Kim CS; Park JK; Chung BH
    Yonsei Med J; 2010 May; 51(3):432-7. PubMed ID: 20376898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prostate: how to treat this symbol of male vulnerability? An Association Française d'Urologie (AFU)-IPSOS qualitative survey].
    Yves B; de la Taille A; Chartier-Kastler E; Moreau JL; Davin JL; Mignard JP; Coulange C; Allegre JP; Averous M; Botto H; Coloby P; Conort P; Delmas V; Desgrandchamps F; Fourcade RO; Grall J; Grise P; Kouri G; Le Doze H; Piechaud T; Prunet D; Rambeaud JJ; Rebillard X; Soulie M; Vignes B; Villers A;
    Prog Urol; 2007 Apr; 17(2):199-202. PubMed ID: 17489318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serious and unexpected complications of benign prostatic obstruction surgery: Results of the LUTS Committee survey from urologists of the French Urological Association].
    Misraï V; Barry Delongchamps N; Lebdai S; Azzouzi AR; Benchikh A; Cornu JN; Dumonceau O; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Sep; 25(10):583-9. PubMed ID: 26159052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia.
    Rahman F; Putra IB; Mochtar CA; Rasyid N
    Prostate Int; 2019 Mar; 7(1):35-40. PubMed ID: 30937297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of neurogenic bladder patients in The Netherlands: do urologists follow guidelines?
    Rikken B; Blok BF
    Neurourol Urodyn; 2008; 27(8):758-62. PubMed ID: 18508332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of bladder and kidney functioning in adult spina bifida patients by Dutch urologists: a survey.
    Veenboer PW; Ruud Bosch JL; de Kort LM
    Neurourol Urodyn; 2014 Mar; 33(3):289-95. PubMed ID: 23897747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign prostatic hyperplasia: clinical manifestations and evaluation.
    Santos Dias J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
    Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
    J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
    Seftel AD; Rosen RC; Rosenberg MT; Sadovsky R
    Int J Clin Pract; 2008 Apr; 62(4):614-22. PubMed ID: 18266709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia.
    Strope SA; Elliott SP; Smith A; Wei JT; Wilt TJ; Saigal CS;
    Urology; 2011 Mar; 77(3):535-40. PubMed ID: 21256570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)].
    Loran OB; Seregin AA
    Urologiia; 2018 May; (2):68-74. PubMed ID: 29901297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool].
    Irani J; Brown C; Van der Meulen J; Emberton M
    Prog Urol; 2004 Feb; 14(1):29-32. PubMed ID: 15098748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.